Dean Bajorin

Dean Bajorin

UNVERIFIED PROFILE

Are you Dean Bajorin?   Register this Author

Register author
Dean Bajorin

Dean Bajorin

Publications by authors named "Dean Bajorin"

Are you Dean Bajorin?   Register this Author

100Publications

4225Reads

5Profile Views

Impact of Teratoma on the Cumulative Incidence of Disease-Related Death in Patients With Advanced Germ Cell Tumors.

J Clin Oncol 2019 Sep 24;37(26):2329-2337. Epub 2019 Jun 24.

Memorial Sloan Kettering Cancer Center, New York, NY and Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.18.01608DOI Listing
September 2019

A New Twist to an Old Tale: Immunotherapy in Non-muscle-invasive Bladder Cancer.

Eur Urol Oncol 2018 08 24;1(3):199-201. Epub 2018 Jul 24.

Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S25889311183010
Publisher Site
http://dx.doi.org/10.1016/j.euo.2018.07.001DOI Listing
August 2018

Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine Plus Cisplatin in Patients With Muscle-Invasive Bladder Cancer.

J Clin Oncol 2018 07 9;36(19):1949-1956. Epub 2018 May 9.

Gopa Iyer, Bernard H. Bochner, Guido Dalbagni, S. Machele Donat, Harry W. Herr, Irina Ostrovnaya, Hikmat Al-Ahmadie, Maria E. Arcila, Jamie C. Riches, Andreas Meier, Caitlin Bourque, Maha Shady, Helen Won, Brooke E. Kania, Mariel E. Boyd, Catharine K. Cipolla, Ashley M. Regazzi, Asia S. McCoy, Hebert Alberto Vargas, Michael F. Berger, David B. Solit, Jonathan E. Rosenberg, and Dean F. Bajorin, Memorial Sloan Kettering Cancer Center; Gopa Iyer, Bernard H. Bochner, Guido Dalbagni, S. Machele Donat, Harry W. Herr, Hikmat Al-Ahmadie, David B. Solit, and Dean F. Bajorin, Weill Cornell Medical College; Arjun V. Balar, William C. Huang, Samir S. Taneja, and Daniela Delbeau, New York University Langone Medical Center, New York, NY; and Matthew I. Milowsky, Michael Woods, Tracy L. Rose, and William Y. Kim, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.0158DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6049398PMC
July 2018

Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit From PD-1/PD-L1 Blockade in Advanced Urothelial Cancers.

J Clin Oncol 2018 06 28;36(17):1685-1694. Epub 2018 Feb 28.

Min Yuen Teo, Kenneth Seier, Irina Ostrovnaya, Ashley M. Regazzi, Brooke E. Kania, Meredith M. Moran, Catharine K. Cipolla, Mark J. Bluth, Joshua Chaim, Alexandra Snyder, Maria I. Carlo, Michael F. Berger, Samuel Funt, Jedd D. Wolchok, Margaret K. Callahan, and Jonathan E. Rosenberg, Memorial Sloan Kettering Cancer Center; and Hikmat Al-Ahmadie, David B. Solit, Gopa Iyer, and Dean F. Bajorin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.7740DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366295PMC
June 2018

Health-Related Quality-of-Life Analysis From KEYNOTE-045: A Phase III Study of Pembrolizumab Versus Chemotherapy for Previously Treated Advanced Urothelial Cancer.

J Clin Oncol 2018 06 28;36(16):1579-1587. Epub 2018 Mar 28.

David J. Vaughn, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; Joaquim Bellmunt and Toni K. Choueiri, Dana-Farber Cancer Institute, Boston, MA; Yves Fradet, CHU de Québec-Université Laval, Quebec City, Quebec, Canada; Jae Lyun Lee, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Republic of Korea; Lawrence Fong, University of California, San Francisco, San Francisco; David I. Quinn, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA; Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Miguel A. Climent, Fundación Instituto Valenciano de Oncología, Valencia, Spain; Daniel P. Petrylak, Smilow Cancer Hospital, Yale University, New Haven, CT; Andrea Necchi, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale dei Tumori, Milan; Cora N. Sternberg, San Camillo and Forlanini Hospitals, Rome, Italy; Winald Gerritsen, Radboud University Medical Center, Nijmegen; Ronald de Wit, Erasmus University Medical Center Cancer Institute, Rotterdam, the Netherlands; Howard Gurney, Westmead Hospital and Macquarie University, Sydney, New South Wales, Australia; Stephane Culine, Hôpital Saint-Louis, Paris, France; Yabing Mai, Haojie Li, and Rodolfo F. Perini, Merk & Co., Inc., Kenilworth, NJ; and Dean F. Bajorin, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2017.76.9562
Publisher Site
http://dx.doi.org/10.1200/JCO.2017.76.9562DOI Listing
June 2018

Global Cancer Transcriptome Quantifies Repeat Element Polarization between Immunotherapy Responsive and T Cell Suppressive Classes.

Cell Rep 2018 Apr;23(2):512-521

Tisch Cancer Institute, Departments of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Oncological Sciences and Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Precision Immunology Institute at the Icahn School of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2018.03.042DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6016853PMC
April 2018

Pembrolizumab for Advanced Urothelial Carcinoma.

N Engl J Med 2017 06;376(23):2304

Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1704612DOI Listing
June 2017

Bilateral Testicular Germ Cell Tumors in the Era of Multimodal Therapy.

Urology 2017 May 2;103:154-160. Epub 2016 Nov 2.

Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2016.10.018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546215PMC
May 2017

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma.

N Engl J Med 2017 03 17;376(11):1015-1026. Epub 2017 Feb 17.

From Dana-Farber Cancer Institute, Boston (J.B., T.K.C.); Parc de Salut Mar, Hospital del Mar Medical Research Institute, Barcelona (J.B.), and Fundación Instituto Valenciano de Oncología, Valencia (M.A.C.) - both in Spain; Erasmus MC Cancer Institute, Rotterdam (R.W.), and Radboud University Medical Center, Nijmegen (W.G.) - both in the Netherlands; Abramson Cancer Center, University of Pennsylvania, Philadelphia (D.J.V.); Centre Hospitalier Universitaire de Québec-Université Laval, Quebec, QC, Canada (Y.F.); Asan Medical Center and University of Ulsan College of Medicine, Seoul, South Korea (J.-L.L.); the University of California, San Francisco, San Francisco (L.F.); Comprehensive Cancer Centers of Nevada, Las Vegas (N.J.V.); Smilow Cancer Hospital, Yale University, New Haven, CT (D.P.P.); Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (A.N.); Westmead Hospital and Macquarie University, Sydney (H.G.); the University of Southern California Norris Comprehensive Cancer Center and Hospital, Los Angeles (D.I.Q.); Hôpital Saint-Louis, Paris (S.C.); San Camillo and Forlanini Hospitals, Rome (C.N.S.); Merck, Kenilworth, NJ (Y.M., C.H.P., R.F.P.); and Memorial Sloan Kettering Cancer Center, New York (D.F.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1613683DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635424PMC
March 2017

Clinical Outcome of Patients with Fibrosis/Necrosis at Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Advanced Germ Cell Tumors.

J Urol 2017 02 5;197(2):391-397. Epub 2016 Oct 5.

Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2016.09.113DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241176PMC
February 2017

Genetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell Tumors.

J Clin Oncol 2016 11 30;34(33):4000-4007. Epub 2016 Sep 30.

Aditya Bagrodia, Byron H. Lee, William Lee, Eugene K. Cha, Gopa Iyer, Eugene J. Pietzak, Sizhi Paul Gao, Emily C. Zabor, Irina Ostrovnaya, Samuel D. Kaffenberger, Aijazuddin Syed, Maria E. Arcila, Raju S. Chaganti, Ritika Kundra, Jana Eng, Joseph Hreiki, Michael F. Berger, Dean F. Bajorin, Manjit S. Bains, Nikolaus Schultz, Victor E. Reuter, Joel Sheinfeld, George J. Bosl, Hikmat A. Al-Ahmadie, David B. Solit, Darren R. Feldman, Memorial Sloan Kettering Cancer Center; John P. Sfakianos, Icahn School of Medicine at Mount Sinai; Gopa Iyer, Michael F. Berger, Dean F. Bajorin, Manjit S. Bains, Victor E. Reuter, Joel Sheinfeld, George J. Bosl, Hikmat A. Al-Ahmadie, David B. Solit, Darren R. Feldman, Weill Cornell Medical College; and Vladimir Vacic, Kanika Arora, Dayna M. Oschwald, New York Genome Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.68.7798DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477828PMC
November 2016

Paclitaxel, Ifosfamide, and Cisplatin Efficacy for First-Line Treatment of Patients With Intermediate- or Poor-Risk Germ Cell Tumors.

J Clin Oncol 2016 07 16;34(21):2478-83. Epub 2016 May 16.

Darren R. Feldman, Kristina Lim, Sujata Patil, Kaitlin M. Woo, Maryann Carousso, Amanda Hughes, Joel Sheinfeld, Manjit Bains, Dean F. Bajorin, George J. Bosl, and Robert J. Motzer, Memorial Sloan Kettering Cancer Center; Darren R. Feldman, Dean F. Bajorin, George J. Bosl, and Robert J. Motzer, Weill Medical College of Cornell University, New York, NY; and James Hu, Tanya B. Dorff, Siamak Daneshmand, Charlene Ketchens, and David I. Quinn, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.66.7899DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320896PMC
July 2016

Identification of a novel susceptibility locus at 13q34 and refinement of the 20p12.2 region as a multi-signal locus associated with bladder cancer risk in individuals of European ancestry.

Authors:
Jonine D Figueroa Candace D Middlebrooks A Rouf Banday Yuanqing Ye Montserrat Garcia-Closas Nilanjan Chatterjee Stella Koutros Lambertus A Kiemeney Thorunn Rafnar Timothy Bishop Helena Furberg Giuseppe Matullo Klaus Golka Manuela Gago-Dominguez Jack A Taylor Tony Fletcher Afshan Siddiq Victoria K Cortessis Charles Kooperberg Olivier Cussenot Simone Benhamou Jennifer Prescott Stefano Porru Colin P Dinney Núria Malats Dalsu Baris Mark P Purdue Eric J Jacobs Demetrius Albanes Zhaoming Wang Charles C Chung Sita H Vermeulen Katja K Aben Tessel E Galesloot Gudmar Thorleifsson Patrick Sulem Kari Stefansson Anne E Kiltie Mark Harland Mark Teo Kenneth Offit Joseph Vijai Dean Bajorin Ryan Kopp Giovanni Fiorito Simonetta Guarrera Carlotta Sacerdote Silvia Selinski Jan G Hengstler Holger Gerullis Daniel Ovsiannikov Meinolf Blaszkewicz Jose Esteban Castelao Manuel Calaza Maria Elena Martinez Patricia Cordeiro Zongli Xu Vijayalakshmi Panduri Rajiv Kumar Eugene Gurzau Kvetoslava Koppova H Bas Bueno-De-Mesquita Börje Ljungberg Françoise Clavel-Chapelon Elisabete Weiderpass Vittorio Krogh Miren Dorronsoro Ruth C Travis Anne Tjønneland Paul Brennan Jenny Chang-Claude Elio Riboli David Conti Marianna C Stern Malcolm C Pike David Van Den Berg Jian-Min Yuan Chancellor Hohensee Rebecca P Jeppson Geraldine Cancel-Tassin Morgan Roupret Eva Comperat Constance Turman Immaculata De Vivo Edward Giovannucci David J Hunter Peter Kraft Sara Lindstrom Angela Carta Sofia Pavanello Cecilia Arici Giuseppe Mastrangelo Ashish M Kamat Liren Zhang Yilei Gong Xia Pu Amy Hutchinson Laurie Burdett William A Wheeler Margaret R Karagas Alison Johnson Alan Schned G M Monawar Hosain Molly Schwenn Manolis Kogevinas Adonina Tardón Consol Serra Alfredo Carrato Reina García-Closas Josep Lloreta Gerald Andriole Robert Grubb Amanda Black W Ryan Diver Susan M Gapstur Stephanie Weinstein Jarmo Virtamo Christopher A Haiman Maria Teresa Landi Neil E Caporaso Joseph F Fraumeni Paolo Vineis Xifeng Wu Stephen J Chanock Debra T Silverman Ludmila Prokunina-Olsson Nathaniel Rothman

Hum Mol Genet 2016 Mar 4;25(6):1203-14. Epub 2016 Jan 4.

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/hmg/ddv492DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4817084PMC
March 2016

Barriers to a Career Focus in Cancer Prevention: A Report and Initial Recommendations From the American Society of Clinical Oncology Cancer Prevention Workforce Pipeline Work Group.

J Clin Oncol 2016 Jan 2;34(2):186-93. Epub 2015 Nov 2.

Carol J. Fabian, University of Kansas Medical Center, Kansas City, KS; Frank L. Meyskens Jr, University of California at Irvine, Irvine, CA; Dean F. Bajorin, Memorial Sloan Kettering Cancer Center, New York, NY; Thomas J. George Jr, University of Florida, Gainesville, FL; Joanne M. Jeter, University of Arizona, Tucson, AZ; Shakila Khan, Mayo Clinic, Rochester, MN; Courtney A. Tyne, Feinstein Kean Healthcare, Washington, DC; and William N. William Jr, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.5979DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070551PMC
January 2016

Phase I Study of Everolimus in Combination with Gemcitabine and Split-Dose Cisplatin in Advanced Urothelial Carcinoma.

Bladder Cancer 2016 Jan 7;2(1):111-117. Epub 2016 Jan 7.

Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/BLC-150038DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927849PMC
January 2016

Association Between Geographic Access to Cancer Care, Insurance, and Receipt of Chemotherapy: Geographic Distribution of Oncologists and Travel Distance.

J Clin Oncol 2015 Oct 24;33(28):3177-85. Epub 2015 Aug 24.

Chun Chieh Lin and Ahmedin Jemal, American Cancer Society, Atlanta, GA; Suanna S. Bruinooge, M. Kelsey Kirkwood, and Amy Hanley, American Society of Clinical Oncology, Alexandria; Anna Arnone and Stephanie Stevens, American Society for Radiation Oncology, Fairfax, VA; Christine Olsen, Massachusetts General Hospital; Michael Goldstein, Beth Israel Deaconess Medical Center, Boston, MA; Dean Bajorin, Memorial Sloan Kettering Cancer Center; Dawn L. Hershman, Columbia University Medical Center, New York, NY; Sharon H. Giordano and B. Ashleigh Guadagnolo, The University of Texas MD Anderson Cancer Center, Houston, TX; Michael Kosty, Scripps Clinic, La Jolla, CA; Shane Hopkins, William R. Bliss Cancer Center, Ames, IA; and James B. Yu, Yale University School of Medicine, New Haven, CT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.61.1558DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979096PMC
October 2015

First-line treatment and prognostic factors of metastatic bladder cancer for platinum-eligible patients.

Hematol Oncol Clin North Am 2015 Apr 15;29(2):319-28, ix-x. Epub 2014 Dec 15.

Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2014.10.005DOI Listing
April 2015

Rates of teratoma and viable cancer at post-chemotherapy retroperitoneal lymph node dissection after induction chemotherapy for good risk nonseminomatous germ cell tumors.

J Urol 2015 Feb 20;193(2):513-8. Epub 2014 Aug 20.

Urology Service, Department of Surgery, and the Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://ac.els-cdn.com/S0022534714042542/1-s2.0-S002253471404
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S002253471404254
Publisher Site
http://dx.doi.org/10.1016/j.juro.2014.08.081DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4354932PMC
February 2015

Synthetic lethality in ATM-deficient RAD50-mutant tumors underlies outlier response to cancer therapy.

Cancer Discov 2014 Sep 16;4(9):1014-21. Epub 2014 Jun 16.

Department of Medicine, University of California, San Francisco, California. Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California. Department of Epidemiology and Biostatistics, University of California, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-14-0380DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155059PMC
September 2014

Reply to C. Anderson and J.M. Buatti.

J Oncol Pract 2014 Jul 13;10(4):e284. Epub 2014 May 13.

University of Iowa, Iowa City, IA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JOP.2014.001444
Publisher Site
http://dx.doi.org/10.1200/JOP.2014.001444DOI Listing
July 2014

The impact of smoking on pathologic response to neoadjuvant cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer.

World J Urol 2014 Apr 11;32(2):453-9. Epub 2013 Jul 11.

Department of Surgery, Urology Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00345-013-1128-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905053PMC
April 2014

Highlights from the first symposium on upper tract urothelial carcinoma.

Urol Oncol 2014 Apr 4;32(3):309-16. Epub 2014 Jan 4.

Zickler Laboratory of Chemical Biology, Health Sciences Center, Stony Brook University, Stony Brook, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2013.08.029DOI Listing
April 2014

Take care of yourself: we need you.

J Clin Oncol 2014 Apr 10;32(11):1101-3. Epub 2014 Mar 10.

Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.54.5319DOI Listing
April 2014

Where do patients with cancer in Iowa receive radiation therapy?

J Oncol Pract 2014 Jan;10(1):20-5

University of Iowa, Iowa City, IA; Beth Israel Deaconess Medical Center, Boston, MA; Memorial Sloan-Kettering Cancer Center, New York, NY; Scripps Clinic, La Jolla, CA; American Society of Clinical Oncology, Alexandria, VA; and West Virginia University School of Medicine, Morgantown, WV.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JOP.2013.001191
Publisher Site
http://dx.doi.org/10.1200/JOP.2013.001191DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706138PMC
January 2014

Access to chemotherapy services by availability of local and visiting oncologists.

J Oncol Pract 2014 Jan;10(1):26-31

University of Iowa, Iowa City, IA; Memorial Sloan-Kettering Cancer Center, New York, NY; Beth Israel Deaconess Medical Center, Boston, MA; Scripps Clinic, La Jolla, CA; and American Society of Clinical Oncology, Alexandria, VA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2013.001217DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889218PMC
January 2014

Enhancing the American Society of Clinical Oncology workforce information system with geographic distribution of oncologists and comparison of data sources for the number of practicing oncologists.

J Oncol Pract 2014 Jan;10(1):32-8

American Society of Clinical Oncology, Alexandria, VA; Beth Israel Deaconess Medical Center, Boston, MA; Memorial Sloan-Kettering Cancer Center, New York, NY; and Scripps Clinic, La Jolla, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2013.001311DOI Listing
January 2014

Projected supply of and demand for oncologists and radiation oncologists through 2025: an aging, better-insured population will result in shortage.

J Oncol Pract 2014 Jan;10(1):39-45

The Lewin Group, Falls Church; American Society of Clinical Oncology, Alexandria, VA; South Texas Oncology and Hematology, San Antonio, TX; Scripps Clinic, La Jolla, CA; Memorial Sloan-Kettering Cancer Center, New York, NY; and Beth Israel Deaconess Medical Center, Boston, MA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JOP.2013.001319
Publisher Site
http://dx.doi.org/10.1200/JOP.2013.001319DOI Listing
January 2014

Phase II study of everolimus in metastatic urothelial cancer.

BJU Int 2013 Aug 3;112(4):462-70. Epub 2013 Apr 3.

Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2012.11720.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020005PMC
August 2013

Prognostic model for predicting survival of patients with metastatic urothelial cancer treated with cisplatin-based chemotherapy.

J Natl Cancer Inst 2013 Apr 14;105(7):499-503. Epub 2013 Feb 14.

Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djt015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691944PMC
April 2013

Body mass index is associated with higher lymph node counts during retroperitoneal lymph node dissection.

Urology 2012 Feb 14;79(2):361-4. Epub 2011 Dec 14.

Department of Surgery-Urology Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2011.04.050DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170790PMC
February 2012

New data, new paradigms for treating prostate cancer patients--VI: novel hormonal therapy approaches.

Urology 2011 Nov;78(5 Suppl):S494-8

Department of Solid Tumor Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2011.06.058DOI Listing
November 2011

Regional lymph node status in patients with bladder cancer found to be pathological stage T0 at radical cystectomy following systemic chemotherapy.

BJU Int 2011 Oct 14;108(8 Pt 2):E272-7. Epub 2011 Feb 14.

Department of Surgery, Urology Section, Memorial Sloan-Kettering Cancer Center, 1275 York Ave Box 213, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2010.09981.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4319321PMC
October 2011

Retrospective analysis of satraplatin in patients with metastatic urothelial cancer refractory to standard platinum-based chemotherapy.

Clin Genitourin Cancer 2011 Sep 22;9(1):27-30. Epub 2011 Jun 22.

Mount Sinai School of Medicine/Tisch Cancer Institute, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2011.05.003DOI Listing
September 2011

Treatment of patients with metastatic urothelial cancer "unfit" for Cisplatin-based chemotherapy.

J Clin Oncol 2011 Jun 9;29(17):2432-8. Epub 2011 May 9.

Mount Sinai School of Medicine, Tisch Cancer Institute, 1 Gustave L. Levy Place, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2011.34.8433DOI Listing
June 2011

Management of invasive bladder cancer in patients who are not candidates for or decline cystectomy.

Ther Adv Urol 2011 Jun;3(3):107-17

Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1756287211407543DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3159398PMC
June 2011

Contemporary lymph node counts during primary retroperitoneal lymph node dissection.

Urology 2011 Feb 15;77(2):368-72. Epub 2010 Dec 15.

Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2010.05.020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4012337PMC
February 2011

Novel strategies for treating relapsed/refractory urothelial carcinoma.

Expert Rev Anticancer Ther 2010 Dec;10(12):1917-32

Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/era.10.182DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705930PMC
December 2010